Chief Executive Officer

SVP - General Counsel

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Institution	Shares	Value	Change
BlackRock	14,025,816	$991M	INCREASED
State Street	5,980,370	$423M	INCREASED
Massachusetts Financial Services Co /MA	2,746,462	$194M	DECREASED
Sumitomo Mitsui Trust Group	2,067,324	$146M	INCREASED
BNY Mellon	1,278,196	$90M	DECREASED

Insider	Type	Shares	Value	Date
James Hippel (CFO)	SELL	51,024	$4M	2026-07-29
James Hippel (CFO)	EXERCISE	62,068	$3M	2026-07-29
Kim Kelderman (Chief Executive Officer)	SELL	28,686	$2M	2026-07-28
Kim Kelderman (Chief Executive Officer)	EXERCISE	35,000	$2M	2026-07-28
Shane Bohnen (SVP - General Counsel)	SELL	344	$25K	2026-07-23

Bio-Techne Corp. (TECH) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades